Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q3 2024 · 10-Q
Revenue$825.78K$825.78K+31.1% vs Q3 2023 Net Income-$2.77M-$2.77MN/M vs Q3 2023 EPS Diluted-$0.10-$0.10N/M vs Q3 2023 Gross Profit$281,872+15.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,360,403N/M Free Cash Flowderived-$2,375,204N/M Margins · derivedGross margin34.1%−4.5 pt vs Q3 2023
Operating margin-338.3%+218.9 pt vs Q3 2023
Net margin-335.1%+215.5 pt vs Q3 2023
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end